c4-2b Search Results


c4 2b atcc crl 3315  (ATCC)
94
ATCC c4 2b atcc crl 3315
C4 2b Atcc Crl 3315, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c4-2b/C4-2B%3B+Prostate+Cancer%3B+Human/10__3892_slash_or__2024__8698-90-0-1
Average 94 stars, based on 1 article reviews
c4 2b atcc crl 3315 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
helix a549  (ATCC)
97
ATCC helix a549
Helix A549, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c4-2b/C4-2B/pm41892485-72-27-42
Average 97 stars, based on 1 article reviews
helix a549 - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
c4-2 cell line  (Viromed Inc)
90
Viromed Inc c4-2 cell line
C4 2 Cell Line, supplied by Viromed Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c4-2b/c4+2b+cells/pmc03680511-55-10-32
Average 90 stars, based on 1 article reviews
c4-2 cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
prostate cancer cell lines c4-2b  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare prostate cancer cell lines c4-2b
Prostate Cancer Cell Lines C4 2b, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c4-2b/c4+2b+cell+line/pm15107617-41-0-18
Average 90 stars, based on 1 article reviews
prostate cancer cell lines c4-2b - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
c4-2b prostate cancer cells  (Corning Life Sciences)
90
Corning Life Sciences c4-2b prostate cancer cells
C4 2b Prostate Cancer Cells, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c4-2b/c4+2b+prostate+cancer+cells/pmc05030109-135-5-30
Average 90 stars, based on 1 article reviews
c4-2b prostate cancer cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
human pca cells c4-2b  (UroCor Inc)
90
UroCor Inc human pca cells c4-2b
Human Pca Cells C4 2b, supplied by UroCor Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c4-2b/c4+2b/pmc05823632-129-0-18
Average 90 stars, based on 1 article reviews
human pca cells c4-2b - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
c4-2b_ enzr cells  (GemPharmatech Co Ltd)
90
GemPharmatech Co Ltd c4-2b_ enzr cells
C4 2b Enzr Cells, supplied by GemPharmatech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c4-2b/c4+2b++enzr+cells/pm39696559-83-21-8
Average 90 stars, based on 1 article reviews
c4-2b_ enzr cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
ikarus c42b  (Comco Inc)
90
Comco Inc ikarus c42b
Overview of the victims in small aircraft accidents
Ikarus C42b, supplied by Comco Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c4-2b/ikarus+c42b/pmc05830469-6-10-9
Average 90 stars, based on 1 article reviews
ikarus c42b - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
c4 2b  (Keygen Biotech)
86
Keygen Biotech c4 2b
UBE2M is highly expressed in prostate cancer and correlates with adverse clinicopathological features. (A) Analysis of UBE2M mRNA expression in the GEPIA2 database. The box plot shows significantly higher UBE2M levels in PCa ( n = 492) compared to normal tissues ( n = 152). (B) Representative immunohistochemistry (IHC) images of UBE2M protein expression in adjacent normal and prostate cancer tissues from a tissue microarray. (C) Quantification of IHC staining scores confirms upregulated UBE2M expression in prostate cancer tissues ( n = 59) compared to adjacent normal tissues ( n = 36). (D) Western blot analysis of UBE2M protein levels in six paired human prostate tumors (T) and their matched adjacent non-tumor tissues (N). GAPDH serves as a loading control. (E) Western blot analysis of UBE2M expression in the normal prostate epithelial cell line RWPE-1 and a panel of prostate cancer cell lines (PC-3, DU145, 22Rv1, <t>C4-2B).</t> (F) OS by UBE2M expression. Kaplan-Meier analysis shows no significant difference between groups. Dotted lines indicate 95% confidence intervals. (G) DFS by UBE2M expression. High UBE2M expression is associated with significantly worse DFS. Dotted lines indicate 95% confidence intervals. Significance is denoted as * p < 0.05, ** p < 0.01
C4 2b, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c4-2b/2b+c4/pmc13123242-68-15-23
Average 86 stars, based on 1 article reviews
c4 2b - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
c4-2b mdvr cells  (Federation of European Neuroscience Societies)
90
Federation of European Neuroscience Societies c4-2b mdvr cells
UBE2M is highly expressed in prostate cancer and correlates with adverse clinicopathological features. (A) Analysis of UBE2M mRNA expression in the GEPIA2 database. The box plot shows significantly higher UBE2M levels in PCa ( n = 492) compared to normal tissues ( n = 152). (B) Representative immunohistochemistry (IHC) images of UBE2M protein expression in adjacent normal and prostate cancer tissues from a tissue microarray. (C) Quantification of IHC staining scores confirms upregulated UBE2M expression in prostate cancer tissues ( n = 59) compared to adjacent normal tissues ( n = 36). (D) Western blot analysis of UBE2M protein levels in six paired human prostate tumors (T) and their matched adjacent non-tumor tissues (N). GAPDH serves as a loading control. (E) Western blot analysis of UBE2M expression in the normal prostate epithelial cell line RWPE-1 and a panel of prostate cancer cell lines (PC-3, DU145, 22Rv1, <t>C4-2B).</t> (F) OS by UBE2M expression. Kaplan-Meier analysis shows no significant difference between groups. Dotted lines indicate 95% confidence intervals. (G) DFS by UBE2M expression. High UBE2M expression is associated with significantly worse DFS. Dotted lines indicate 95% confidence intervals. Significance is denoted as * p < 0.05, ** p < 0.01
C4 2b Mdvr Cells, supplied by Federation of European Neuroscience Societies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c4-2b/c4+2b+mdvr+cells/pm36254631-301-9-25
Average 90 stars, based on 1 article reviews
c4-2b mdvr cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
luciferase transfected c4 2b luc  (Biochrom)
86
Biochrom luciferase transfected c4 2b luc
UBE2M is highly expressed in prostate cancer and correlates with adverse clinicopathological features. (A) Analysis of UBE2M mRNA expression in the GEPIA2 database. The box plot shows significantly higher UBE2M levels in PCa ( n = 492) compared to normal tissues ( n = 152). (B) Representative immunohistochemistry (IHC) images of UBE2M protein expression in adjacent normal and prostate cancer tissues from a tissue microarray. (C) Quantification of IHC staining scores confirms upregulated UBE2M expression in prostate cancer tissues ( n = 59) compared to adjacent normal tissues ( n = 36). (D) Western blot analysis of UBE2M protein levels in six paired human prostate tumors (T) and their matched adjacent non-tumor tissues (N). GAPDH serves as a loading control. (E) Western blot analysis of UBE2M expression in the normal prostate epithelial cell line RWPE-1 and a panel of prostate cancer cell lines (PC-3, DU145, 22Rv1, <t>C4-2B).</t> (F) OS by UBE2M expression. Kaplan-Meier analysis shows no significant difference between groups. Dotted lines indicate 95% confidence intervals. (G) DFS by UBE2M expression. High UBE2M expression is associated with significantly worse DFS. Dotted lines indicate 95% confidence intervals. Significance is denoted as * p < 0.05, ** p < 0.01
Luciferase Transfected C4 2b Luc, supplied by Biochrom, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c4-2b/luciferase+transfected+c4+2b+luc/pmc04259356-261-7-36
Average 86 stars, based on 1 article reviews
luciferase transfected c4 2b luc - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
c4 2b human prostate cancer cell line  (Viromed Inc)
86
Viromed Inc c4 2b human prostate cancer cell line
UBE2M is highly expressed in prostate cancer and correlates with adverse clinicopathological features. (A) Analysis of UBE2M mRNA expression in the GEPIA2 database. The box plot shows significantly higher UBE2M levels in PCa ( n = 492) compared to normal tissues ( n = 152). (B) Representative immunohistochemistry (IHC) images of UBE2M protein expression in adjacent normal and prostate cancer tissues from a tissue microarray. (C) Quantification of IHC staining scores confirms upregulated UBE2M expression in prostate cancer tissues ( n = 59) compared to adjacent normal tissues ( n = 36). (D) Western blot analysis of UBE2M protein levels in six paired human prostate tumors (T) and their matched adjacent non-tumor tissues (N). GAPDH serves as a loading control. (E) Western blot analysis of UBE2M expression in the normal prostate epithelial cell line RWPE-1 and a panel of prostate cancer cell lines (PC-3, DU145, 22Rv1, <t>C4-2B).</t> (F) OS by UBE2M expression. Kaplan-Meier analysis shows no significant difference between groups. Dotted lines indicate 95% confidence intervals. (G) DFS by UBE2M expression. High UBE2M expression is associated with significantly worse DFS. Dotted lines indicate 95% confidence intervals. Significance is denoted as * p < 0.05, ** p < 0.01
C4 2b Human Prostate Cancer Cell Line, supplied by Viromed Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c4-2b/pmc08665135-34-0-9
Average 86 stars, based on 1 article reviews
c4 2b human prostate cancer cell line - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


Overview of the victims in small aircraft accidents

Journal: Forensic Science, Medicine, and Pathology

Article Title: Postmortem radiological case series of acetabular fractures after fatal aviation accidents

doi: 10.1007/s12024-018-9946-1

Figure Lengend Snippet: Overview of the victims in small aircraft accidents

Article Snippet: A4 , M (39) , Yes , Land , Comco Ikarus C42B , Crash into house , X ray.

Techniques: Imaging

UBE2M is highly expressed in prostate cancer and correlates with adverse clinicopathological features. (A) Analysis of UBE2M mRNA expression in the GEPIA2 database. The box plot shows significantly higher UBE2M levels in PCa ( n = 492) compared to normal tissues ( n = 152). (B) Representative immunohistochemistry (IHC) images of UBE2M protein expression in adjacent normal and prostate cancer tissues from a tissue microarray. (C) Quantification of IHC staining scores confirms upregulated UBE2M expression in prostate cancer tissues ( n = 59) compared to adjacent normal tissues ( n = 36). (D) Western blot analysis of UBE2M protein levels in six paired human prostate tumors (T) and their matched adjacent non-tumor tissues (N). GAPDH serves as a loading control. (E) Western blot analysis of UBE2M expression in the normal prostate epithelial cell line RWPE-1 and a panel of prostate cancer cell lines (PC-3, DU145, 22Rv1, C4-2B). (F) OS by UBE2M expression. Kaplan-Meier analysis shows no significant difference between groups. Dotted lines indicate 95% confidence intervals. (G) DFS by UBE2M expression. High UBE2M expression is associated with significantly worse DFS. Dotted lines indicate 95% confidence intervals. Significance is denoted as * p < 0.05, ** p < 0.01

Journal: Journal of Translational Medicine

Article Title: UBE2M promotes malignant phenotypes of prostate cancer through mediating NAA10 neddylation

doi: 10.1186/s12967-026-08001-8

Figure Lengend Snippet: UBE2M is highly expressed in prostate cancer and correlates with adverse clinicopathological features. (A) Analysis of UBE2M mRNA expression in the GEPIA2 database. The box plot shows significantly higher UBE2M levels in PCa ( n = 492) compared to normal tissues ( n = 152). (B) Representative immunohistochemistry (IHC) images of UBE2M protein expression in adjacent normal and prostate cancer tissues from a tissue microarray. (C) Quantification of IHC staining scores confirms upregulated UBE2M expression in prostate cancer tissues ( n = 59) compared to adjacent normal tissues ( n = 36). (D) Western blot analysis of UBE2M protein levels in six paired human prostate tumors (T) and their matched adjacent non-tumor tissues (N). GAPDH serves as a loading control. (E) Western blot analysis of UBE2M expression in the normal prostate epithelial cell line RWPE-1 and a panel of prostate cancer cell lines (PC-3, DU145, 22Rv1, C4-2B). (F) OS by UBE2M expression. Kaplan-Meier analysis shows no significant difference between groups. Dotted lines indicate 95% confidence intervals. (G) DFS by UBE2M expression. High UBE2M expression is associated with significantly worse DFS. Dotted lines indicate 95% confidence intervals. Significance is denoted as * p < 0.05, ** p < 0.01

Article Snippet: The human immortalized prostate epithelial cell line RWPE-1 and prostate cancer (PCa) cell lines, including C4-2B, PC-3, DU-145, and 22Rv1, were purchased from KeyGEN BioTECH (Jiangsu, China).

Techniques: Expressing, Immunohistochemistry, Microarray, Western Blot, Control